NDC Active Ingredient Auranofin

Active Ingredient Information

What is Auranofin?

An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.

What is the usage for Auranofin?

This medication is used as part of a complete treatment program including non-drug therapies (e.g., rest, physical therapy) to treat active rheumatoid arthritis. It is used to treat patients with severe rheumatoid arthritis who have not responded to or cannot take other medications. Auranofin is a gold compound. Auranofin is not a true pain reliever (e.g., like aspirin) but it is thought to decrease pain that occurs with arthritis by decreasing inflammation. It is known as a disease-modifying antirheumatic drug (DMARD). It decreases morning stiffness and pain/swelling in joints and can increase grip strength.

How many products in the NDC database contain Auranofin?

The NDC database has 2 products with the active ingredient Auranofin. The following table lists all the products that have this active ingredient.

NDC Products with Auranofin

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
49812-0067Proprietary Name: AuranofinPowderVeranova, L.p.ACTIVE
54766-093Proprietary Name: Ridaura AuranofinCapsuleOralSebela Pharmaceuticals Inc.ACTIVE